My NCBI | Sign In
RSS Settings
  • Search:

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 139

    1.

    The effect of statin therapy on endothelial function in type 2 diabetes without manifest cardiovascular disease.

    Beishuizen ED, Tamsma JT, Jukema JW, van de Ree MA, van der Vijver JC, Meinders AE, Huisman MV.

    Diabetes Care. 2005 Jul;28(7):1668-74.PMID: 15983318 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Two-year statin therapy does not alter the progression of intima-media thickness in patients with type 2 diabetes without manifest cardiovascular disease.

    Beishuizen ED, van de Ree MA, Jukema JW, Tamsma JT, van der Vijver JC, Meinders AE, Putter H, Huisman MV.

    Diabetes Care. 2004 Dec;27(12):2887-92.PMID: 15562202 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    No effect of statin therapy on silent myocardial ischemia in patients with type 2 diabetes without manifest cardiovascular disease.

    Beishuizen ED, Jukema JW, Tamsma JT, van de Ree MA, van der Vijver JC, Putter H, Maan AC, Meinders AE, Huisman MV.

    Diabetes Care. 2005 Jul;28(7):1675-9.PMID: 15983319 [PubMed - indexed for MEDLINE]Related articlesFree article

    4.

    Intense cholesterol lowering therapy with a HMG-CoA reductase inhibitor does not improve nitric oxide dependent endothelial function in type-2-diabetes--a multicenter, randomised, double-blind, three-arm placebo-controlled clinical trial.

    Balletshofer BM, Goebbel S, Rittig K, Enderle M, Schmölzer I, Wascher TC, Ferenc Pap A, Westermeier T, Petzinna D, Matthaei S, Häring HU.

    Exp Clin Endocrinol Diabetes. 2005 Jun;113(6):324-30.PMID: 15977099 [PubMed - indexed for MEDLINE]Related articles

    5.

    The effects of troglitazone, an insulin-sensitizing agent, on the endothelial function in early and late type 2 diabetes: a placebo-controlled randomized clinical trial.

    Caballero AE, Saouaf R, Lim SC, Hamdy O, Abou-Elenin K, O'Connor C, Logerfo FW, Horton ES, Veves A.

    Metabolism. 2003 Feb;52(2):173-80.PMID: 12601628 [PubMed - indexed for MEDLINE]Related articles

    6.

    Coenzyme Q10 improves endothelial dysfunction in statin-treated type 2 diabetic patients.

    Hamilton SJ, Chew GT, Watts GF.

    Diabetes Care. 2009 May;32(5):810-2. Epub 2009 Feb 19.PMID: 19228872 [PubMed - indexed for MEDLINE]Related articlesFree article

    7.

    Oxidized-LDL levels are changed during short-term serum glucose variations and lowered with statin treatment in early Type 2 diabetes: a study of endothelial function and microalbuminuria.

    Paniagua JA, López-Miranda J, Pérez-Martínez P, Marín C, Vida JM, Fuentes F, Fernández de la Puebla RA, Pérez-Jiménez F.

    Diabet Med. 2005 Dec;22(12):1647-56.PMID: 16401307 [PubMed - indexed for MEDLINE]Related articles

    8.

    Aggressive lipid lowering does not improve endothelial function in type 2 diabetes: the Diabetes Atorvastatin Lipid Intervention (DALI) Study: a randomized, double-blind, placebo-controlled trial.

    van Venrooij FV, van de Ree MA, Bots ML, Stolk RP, Huisman MV, Banga JD; DALI Study Group.

    Diabetes Care. 2002 Jul;25(7):1211-6.PMID: 12087021 [PubMed - indexed for MEDLINE]Related articlesFree article

    9.

    Microvascular endothelial function in subjects with Type 2 diabetes and the effect of lipid-lowering therapy.

    Fegan PG, Shore AC, Mawson D, Tooke JE, MacLeod KM.

    Diabet Med. 2005 Dec;22(12):1670-6.PMID: 16401310 [PubMed - indexed for MEDLINE]Related articles

    10.

    Early statin therapy restores endothelial function in children with familial hypercholesterolemia.

    de Jongh S, Lilien MR, op't Roodt J, Stroes ES, Bakker HD, Kastelein JJ.

    J Am Coll Cardiol. 2002 Dec 18;40(12):2117-21.PMID: 12505222 [PubMed - indexed for MEDLINE]Related articles

    11.

    The effects of atorvastatin on endothelial function in diabetic patients and subjects at risk for type 2 diabetes.

    Economides PA, Caselli A, Tiani E, Khaodhiar L, Horton ES, Veves A.

    J Clin Endocrinol Metab. 2004 Feb;89(2):740-7.PMID: 14764790 [PubMed - indexed for MEDLINE]Related articlesFree article

    12.

    Impaired endothelium-dependent vasodilation in type 2 diabetes mellitus and the lack of effect of simvastatin.

    van de Ree MA, Huisman MV, de Man FH, van der Vijver JC, Meinders AE, Blauw GJ.

    Cardiovasc Res. 2001 Nov;52(2):299-305.PMID: 11684078 [PubMed - indexed for MEDLINE]Related articlesFree article

    13.

    Effects of rosuvastatin on endothelial function in patients with familial combined hyperlipidaemia (FCH).

    ter Avest E, Abbink EJ, Holewijn S, de Graaf J, Tack CJ, Stalenhoef AF.

    Curr Med Res Opin. 2005 Sep;21(9):1469-76.PMID: 16197666 [PubMed - indexed for MEDLINE]Related articles

    14.

    Effects of pioglitazone on endothelial function, insulin sensitivity, and glucose control in subjects with coronary artery disease and new-onset type 2 diabetes.

    Sourij H, Zweiker R, Wascher TC.

    Diabetes Care. 2006 May;29(5):1039-45.PMID: 16644634 [PubMed - indexed for MEDLINE]Related articlesFree article

    15.

    Effect of statin versus fibrate on postprandial endothelial dysfunction: role of remnant-like particles.

    Wilmink HW, Twickler MB, Banga JD, Dallinga-Thie GM, Eeltink H, Erkelens DW, Rabelink TJ, Stroes ES.

    Cardiovasc Res. 2001 Jun;50(3):577-82.PMID: 11376633 [PubMed - indexed for MEDLINE]Related articlesFree article

    16.

    Cholesterol lowering is more important than pleiotropic effects of statins for endothelial function in patients with dysglycaemia and coronary artery disease.

    Settergren M, Böhm F, Rydén L, Pernow J.

    Eur Heart J. 2008 Jul;29(14):1753-60. Epub 2008 Apr 25.PMID: 18441323 [PubMed - indexed for MEDLINE]Related articlesFree article

    17.

    A randomized trial of the effect of statin and fibrate therapy on arterial function in CKD.

    Dogra G, Irish A, Chan D, Watts G.

    Am J Kidney Dis. 2007 Jun;49(6):776-85.PMID: 17533020 [PubMed - indexed for MEDLINE]Related articles

    18.

    High-dose atorvastatin in peripheral arterial disease (PAD): effect on endothelial function, intima-media-thickness and local progression of PAD. An open randomized controlled pilot trial.

    Spring S, Simon R, van der Loo B, Kovacevic T, Brockes C, Rousson V, Amann-Vesti B, Koppensteiner R.

    Thromb Haemost. 2008 Jan;99(1):182-9.PMID: 18217152 [PubMed - indexed for MEDLINE]Related articles

    19.

    Short-term pioglitazone treatment improves vascular function irrespective of metabolic changes in patients with type 2 diabetes.

    Martens FM, Visseren FL, de Koning EJ, Rabelink TJ.

    J Cardiovasc Pharmacol. 2005 Dec;46(6):773-8.PMID: 16306801 [PubMed - indexed for MEDLINE]Related articles

    20.

    Chronic administration of Sildenafil improves markers of endothelial function in men with Type 2 diabetes.

    Aversa A, Vitale C, Volterrani M, Fabbri A, Spera G, Fini M, Rosano GM.

    Diabet Med. 2008 Jan;25(1):37-44.PMID: 18199130 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Filter your results:

    Find related data

    Recent activity